Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4841)
All Articles published online
|
Oct 6, 2012 (publication date) through Jun 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Seki G, Endo Y, Suzuki M, Yamada H, Horita S, Fujita T. Role of renal proximal tubule transport in thiazolidinedione-induced volume expansion. World J Nephrol 2012; 1(5): 146-150 [PMID: 24175252 DOI: 10.5527/wjn.v1.i5.146] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v1/i5/146.htm |
| Number | Citing Articles |
| 1 |
Lorenzo Nesti, Domenico Tricò, Alessandro Mengozzi, Andrea Natali. Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug. Cardiovascular Diabetology 2021; 20(1) doi: 10.1186/s12933-021-01294-7
|
| 2 |
Michael Nassif, Mikhail Kosiborod. Effect of glucose-lowering therapies on heart failure. Nature Reviews Cardiology 2018; 15(5): 282 doi: 10.1038/nrcardio.2017.211
|
| 3 |
Michael E. Nassif, Mikhail Kosiborod. A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes. The American Journal of Cardiology 2019; 124: S12 doi: 10.1016/j.amjcard.2019.10.025
|
| 4 |
Michael E. Nassif, Mikhail Kosiborod. A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes. The American Journal of Medicine 2019; 132(10): S13 doi: 10.1016/j.amjmed.2019.08.003
|
| 5 |
Terri Jerkins, Janet B. McGill, David S. H. Bell. Heart failure and diabetes: Clinical significance and epidemiology of this two‐way association. Diabetes, Obesity and Metabolism 2023; 25(S3): 3 doi: 10.1111/dom.15062
|
| 6 |
Richard E Gilbert, Henry Krum. Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. The Lancet 2015; 385(9982): 2107 doi: 10.1016/S0140-6736(14)61402-1
|
| 7 |
Wen-Wen Yan, Gui-Hai Chen, Fang Wang, Jing-Jing Tong, Fei Tao. Long-term acarbose administration alleviating the impairment of spatial learning and memory in the SAMP8 mice was associated with alleviated reduction of insulin system and acetylated H4K8. Brain Research 2015; 1603: 22 doi: 10.1016/j.brainres.2015.01.042
|
| 8 |
Jeong Mi Kim, Sang Soo Kim, Jong Ho Kim, Mi Kyung Kim, Tae Nyun Kim, Soon Hee Lee, Chang Won Lee, Ja Young Park, Eun Sook Kim, Kwang Jae Lee, Young Sik Choi, Duk Kyu Kim, In Joo Kim. Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study. Diabetes & Metabolism Journal 2020; 44(1): 67 doi: 10.4093/dmj.2018.0274
|
| 9 |
Michael L. Goodson, Briana M. Young, Chelsea A. Snyder, Amy C. Schroeder, Martin L. Privalsky. Alteration of NCoR Corepressor Splicing in Mice Causes Increased Body Weight and Hepatosteatosis without Glucose Intolerance. Molecular and Cellular Biology 2014; 34(22): 4104 doi: 10.1128/MCB.00554-14
|
| 10 |
David S. H. Bell, Edison Goncalves. Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications. Diabetes, Obesity and Metabolism 2019; 21(6): 1277 doi: 10.1111/dom.13652
|
| 11 |
Rabea Asleh, Mohammad Sheikh-Ahmad, Alexandros Briasoulis, Sudhir S. Kushwaha. The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus. Heart Failure Reviews 2018; 23(3): 445 doi: 10.1007/s10741-017-9666-8
|